title: Renal histopathological lesions after lung transplantation in patients with cystic fibrosis.
abstract: We have analyzed the evolution of renal status beyond the perioperative period in patients with cystic fibrosis (CF) undergoing lung transplantation and presented histological analysis of 15 patients biopsied for an episode of accelerated renal function loss (RFL). Episodes of accelerated RFL after the perioperative period occurred in 32.5% of patients and significantly raised the risk of end-stage renal disease (ESRD) (p < 0.001). The histologic lesions associated with these episodes differed according to the time of onset. Early onset (10 cases) was associated with tubulointerstitial lesions in the form of oxalate nephropathy (50%) and/or a pigmented tubulopathy (80%). This latter was correlated with treatment with antiviral agents (p = 0.002) and aminoside and glycopeptide antibiotics (p = 0.03) administered in the month preceding biopsy. Lesions in late episodes of accelerated RFL (5 cases) were principally vascular: arteriosclerosis and arteriolosclerosis (p = 0.007, p = 0.00002), correlated with diabetic glomerulosclerosis or focal segmental glomerulosclerosis in the absence of prominent diabetic changes. Specific calcineurin-inhibitor nephrotoxicity was present in 93.3% of biopsies associated with thrombotic microangiopathy in 46.7% of cases. The identification of specific etiologies of progressive kidney disease in patients with CF after lung transplantation should permit more effective post-transplant care of these patients.
authors.affiliation: Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital Paris, France. carmen.lefaucheur@wanadoo.fr
authors.forename: C
authors.initials: C
authors.lastname: Lefaucheur
authors.forename: D
authors.initials: D
authors.lastname: Nochy
authors.forename: C
authors.initials: C
authors.lastname: Amrein
authors.forename: P
authors.initials: P
authors.lastname: Chevalier
authors.forename: R
authors.initials: R
authors.lastname: Guillemain
authors.forename: M
authors.initials: M
authors.lastname: Cherif
authors.forename: C
authors.initials: C
authors.lastname: Jacquot
authors.forename: D
authors.initials: D
authors.lastname: Glotz
authors.forename: G S
authors.initials: GS
authors.lastname: Hill
mesh_terms: D001706:Biopsy; D016572:Cyclosporine / Q000009:adverse effects; D003550:Cystic Fibrosis / Q000150:complications*; D003928:Diabetic Nephropathies / Q000209:etiology / Q000473:pathology / Q000601:surgery; D005919:Glomerular Filtration Rate; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000473:pathology / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D007684:Kidney Tubules / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D016040:Lung Transplantation; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus